Lupin和Honeywell开发新的吸入器,将温室气体排放量减少99.9%。 Lupin and Honeywell develop new inhalers that cut greenhouse gas emissions by up to 99.9%.

制药公司Lupin Ltd与Honeywell合作开发新的气喘吸入器, Pharmaceutical company Lupin Ltd has teamed up with Honeywell to develop new inhalers for asthma and COPD patients using Honeywell's 'Solstice Air' propellant. 此举旨在与传统推进剂相比,将温室气体排放量大幅削减99.9%。 This move aims to significantly cut greenhouse gas emissions by up to 99.9% compared to traditional propellants. Lupin试图成为印度第一个大规模使用这一技术的国家,这标志着向更环保的医疗设备迈出了一步。 Lupin seeks to be the first in India to use this technology at a large scale, marking a step towards more environmentally friendly medical devices.